[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
10x Genomics Launches Atara Platform but Revenue Growth Still Depends on Second Half Execution

Barchart Research What to Expect from TXG Earnings TXG Generated August 5, 2026 Current Price $47.46 EPS Estimate $$-0.23 Consensus Rating Moderate Buy Average Move 4.94% 10x Genomics Launches Atara Platform...

TXG : 47.46 (-0.84%)
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

TXG : 47.46 (-0.84%)
1 Surging Stock with Solid Fundamentals and 2 Facing Headwinds

1 Surging Stock with Solid Fundamentals and 2 Facing Headwinds

TXG : 47.46 (-0.84%)
BRK.A : 777,696.00 (+0.44%)
PEBO : 41.60 (-0.36%)
10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care

Collaboration aims to identify biomarkers predictive of treatment response across multiple cancer types using 10x's single cell and spatial platforms

TXG : 47.46 (-0.84%)
1 Healthcare Stock to Keep an Eye On and 2 We Avoid

1 Healthcare Stock to Keep an Eye On and 2 We Avoid

TXG : 47.46 (-0.84%)
CAH : 239.23 (+2.43%)
MRNA : 56.26 (-1.29%)
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

TXG : 47.46 (-0.84%)
HIMS : 31.65 (-1.59%)
RGEN : 158.59 (+5.88%)
WST : 351.02 (+0.65%)
1 Cash-Producing Stock with Exciting Potential and 2 Facing Challenges

1 Cash-Producing Stock with Exciting Potential and 2 Facing Challenges

TXG : 47.46 (-0.84%)
MTCH : 38.15 (-7.49%)
NPO : 328.53 (-1.88%)
3 Russell 2000 Stocks We Steer Clear Of

3 Russell 2000 Stocks We Steer Clear Of

TXG : 47.46 (-0.84%)
EIG : 50.77 (+0.12%)
STBA : 52.60 (-0.15%)
10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026

PLEASANTON, Calif. , July 15, 2026 /PRNewswire/ --  10x Genomics, Inc.  (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, announced...

TXG : 47.46 (-0.84%)
3 Cash-Heavy Stocks We Find Risky

3 Cash-Heavy Stocks We Find Risky

TXG : 47.46 (-0.84%)
DRS : 44.62 (-1.44%)
ZG : 36.89 (-0.38%)

Barchart Exclusives

Amazon’s AI Story Is Bigger Than You Think. Here Are 3 Reasons Why.
Artificial intelligence is driving growth in more than one corner of Amazon's sprawling business. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.